Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Godi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Public Health|November 1, 1988
Obesity in ItalyR Pagano, L Godi, M Cairella
Journal of Neural Transmission. Supplementum|January 1, 1995
Autonomic disorders in Parkinson's diseaseE Martignoni, C Pacchetti, L Godi, et al.
Clinical Physiology (Oxford, England)|September 1, 1995
Effect of 8-day therapy with propionyl-L-carnitine on muscular and subcutaneous blood flow of the lower limbs in patients with peripheral arterial diseaseM Bolognesi, P Amodio, C Merkel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
"Off" painful dystonia in Parkinson's disease treated with botulinum toxinC Pacchetti, G Albani, E Martignoni, et al.
Aging (Milan, Italy)|January 1, 1997
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's diseaseE Martignoni, A Costa, R E Nappi, et al.
Free Radical Biology & Medicine|September 1, 1999
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPAE Martignoni, F Blandini, L Godi, et al.
Functional Neurology|May 1, 1995
Terguride in stable Parkinson's diseaseE Martignoni, C Pacchetti, B Aufdembrinke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Terguride in fluctuating parkinsonian patients: a double-blind study versus placeboC Pacchetti, E Martignoni, P Bruggi, et al.
European Heart Journal|February 1, 1992
Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over studyG Brevetti, S Perna, C Sabbà, et al.
European Heart Journal|October 1, 1994
Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler studyC Sabbá, E Berardi, G Antonica, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Public Health|November 1, 1988
Obesity in ItalyR Pagano, L Godi, M Cairella
Journal of Neural Transmission. Supplementum|January 1, 1995
Autonomic disorders in Parkinson's diseaseE Martignoni, C Pacchetti, L Godi, et al.
Clinical Physiology (Oxford, England)|September 1, 1995
Effect of 8-day therapy with propionyl-L-carnitine on muscular and subcutaneous blood flow of the lower limbs in patients with peripheral arterial diseaseM Bolognesi, P Amodio, C Merkel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
"Off" painful dystonia in Parkinson's disease treated with botulinum toxinC Pacchetti, G Albani, E Martignoni, et al.
Aging (Milan, Italy)|January 1, 1997
Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson's diseaseE Martignoni, A Costa, R E Nappi, et al.
Free Radical Biology & Medicine|September 1, 1999
Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPAE Martignoni, F Blandini, L Godi, et al.
Functional Neurology|May 1, 1995
Terguride in stable Parkinson's diseaseE Martignoni, C Pacchetti, B Aufdembrinke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Terguride in fluctuating parkinsonian patients: a double-blind study versus placeboC Pacchetti, E Martignoni, P Bruggi, et al.
European Heart Journal|February 1, 1992
Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over studyG Brevetti, S Perna, C Sabbà, et al.
European Heart Journal|October 1, 1994
Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler studyC Sabbá, E Berardi, G Antonica, et al.
Pageof 2